- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
- News News
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America
- Join Join
Washington, DC - Americans for Safe Access (ASA) and CannaKeys are partnering together to help broaden access to cannabis research and demystify the science of cannabis to support improved patient outcomes. As part of this partnership, all ASA members will receive a 30% discount on the CannaKeys 360 platform. In addition, ASA and CannaKeys will be working together on educational activities to help accelerate the use and safe adoption of cannabinoid therapeutics.
The CannaKeys 360° platform provides easy access to published science, aggregated critical data points, and guidance to practitioners and patients. CannaKeys provides over 3,500 cannabis related studies across 240+ medical conditions. ASA will be utilizing the CannaKeys platform to help provide data and scientific references to their numerous educational materials, reports, and federal and state comments that they create throughout the year to advance medical cannabis policy and acceptance for cannabis as a medicine.
"Being able to have immediate access to evidence-based research will help us inform policy recommendations that improve policies for patients," said Debbie Churgai, executive director of ASA. "Healthcare workers, researchers, educators, policymakers, businesses and cannabis patients and consumers can all greatly benefit from access to this extensive and growing database. ASA is excited to broaden access to this important resource to all our members.”
“Americans for Safe Access (ASA) has been dedicated to advocating for patient access and working to improve the regulatory landscape of cannabis healthcare for nearly two decades. CannaKeys is thrilled to be working with ASA to increase the pace of change and support their ongoing work by providing platforms that quickly aggregates the science of cannabis and supports improved patient outcomes,” said Douglas Reil, co-founder and CEO of CannaKeys.
To learn more about how science can inform policies for patients, participants can sign up for a free joint webinar with ASA and CannaKeys.
About Americans for Safe Access
Americans for Safe Access (ASA), is the largest national nonprofit, member-based organization of patients, medical professionals, scientists and concerned citizens promoting safe and legal access to cannabis for therapeutic use and research with over 150,000 supporters in all 50 states
The mission of CannaKeys is to empower patients, medical professionals, caregivers, and the industry with the tools to maximize the effectiveness of cannabis therapeutics and create agency with regard to their applications. The company achieves that mission by creating platforms and services that support education on the cannabinoid health sciences and the effective and consistent use of these therapies.